European Healthcare Company | Market Research

Driving Targeted Market Access for a European Healthcare Innovator

Scala Consulting partnered with a Europe-based specialty pharmaceutical company to support its strategic entry into key Southeast Asian markets. With a compact but high-potential product portfolio—including Mesalazine (for inflammatory bowel disease) and Vincamine (a cognitive supplement for aging populations)—the company sought expert guidance to understand regional dynamics and secure the right commercial pathways.

Objective

To assess Southeast Asia’s regulatory and commercial viability for two priority pharmaceutical products, and to identify qualified distribution and licensing partners in markets with strong growth potential.

Our Approach

Scala delivered a two-part engagement focused on market intelligence and localized partner matching:

• Market Research & Regulatory Insight:
  • Conducted in-depth research across multiple Southeast Asian countries to evaluate market demand, competitive positioning, regulatory requirements, and pricing benchmarks for both products.
  • Assessed health system structures and reimbursement environments to guide entry strategy.
• Strategic Partnering & Business Matching: Facilitated initial commercial discussions with potential partners across Vietnam and Hong Kong, including regional pharmaceutical distributors, hospital networks, and licensing agents.

Results

• High-Potential Commercial Traction: Secured promising distribution and partnership leads in Vietnam and Hong Kong, two priority entry markets identified through research.
• Localized Insight for Decision-Making: Enabled the client to move forward with tailored market plans rooted in local data, market realities, and direct partner feedback.